Torii Pharmaceutical Co., Ltd.
OTC: TRXPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Goichi Matsuda
- Employees
- 583
- Headquarters
- Tokyo, Japan
- IPO year
- 2013
- Market cap
- $690.7M
- Website
- https://www.torii.co.jp
Loading TRXPF…
Loading profile data…Frequently asked questions about TRXPF
What does Torii Pharmaceutical Co., Ltd. (TRXPF) do?
Torii Pharmaceutical Co., Ltd., a Tokyo-based Japanese firm established in 1872, specializes in the development and commercialization of a variety of pharmaceutical products. Its therapeutic portfolio features Riona, a medication addressing hyperphosphatemia, and REMITCH, an oral treatment for pruritus commonly experienced by patients undergoing...
Where does TRXPF trade?
Torii Pharmaceutical Co., Ltd. (TRXPF) trades on the Other OTC.
What sector is TRXPF in?
Torii Pharmaceutical Co., Ltd. (TRXPF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Torii Pharmaceutical Co., Ltd.?
Goichi Matsuda is the chief executive officer of Torii Pharmaceutical Co., Ltd. (TRXPF).
Where is Torii Pharmaceutical Co., Ltd. headquartered?
Torii Pharmaceutical Co., Ltd. is headquartered in Japan.
Does TRXPF pay a dividend?
Yes — Torii Pharmaceutical Co., Ltd. (TRXPF) paid a trailing twelve-month dividend of USD 0.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TRXPF go public?
Torii Pharmaceutical Co., Ltd. (TRXPF) completed its initial public offering in 2013.